DSM-FIRMENICH AG

Discover how DSM‑Firmenich’s “Smell‑The‑Taste” tech powers LEI?R’s coffee‑based fragrance ALBA, blending flavor and scent for multi‑sensory innovation.

DSM‑Firmenich beats Q3 expectations with 8% LFL EBITDA growth, raises full‑year outlook to 5% and highlights clean‑label, plant‑based trends that boost future margins.

Medical coatings industry trends 2024‑2030: regulatory hurdles, AI‑driven surfaces, and DSM‑Firmenich’s strategic edge for biocompatible implants.